According to the latest report by IMARC Group, titled “Surgical Sutures Market Report by Type (Absorbable Sutures, Non-Absorbable Sutures), Material (Monofilament, Multifilament), Application (Cardiovascular Surgeries, General Surgeries, Gynecological Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2024-2032,” the global surgical sutures market reached a value of US$ 5.1 Billion in 2023. Surgical sutures refer to medical devices used by doctors and healthcare professionals to close wounds or other tissues after an injury or surgery. These are threads or strands manufactured using natural fibers like silk and synthetic materials, such as polyester, polydioxanone (PDS) and polyglactin. They are usually applied using a needle with an attached thread and secured with a surgical knot. Depending on the requirements, they are widely available in absorbable and non-absorbable variants. Since they have excellent tensile strength, sterility and flexibility, surgical sutures find extensive applications in the healthcare sector.
Global Surgical Sutures Market Trends:
The rising number of individuals undergoing surgical procedures due to improved efficiency and safety represents the primary factor driving the market growth. In addition, the growing geriatric population and the widespread prevalence of chronic ailments, such as cardiovascular diseases (CVDs), arthritis, cancer and obesity, are other major growth-inducing factors. Besides this, a significant rise in fatal road accidents and high hospital admission rates are also escalating the demand for surgical sutures. Furthermore, various key players are launching advanced products like surgical sutures that facilitate scar-free wound healing while minimizing wound tension, ischemia and tissue injury. This, in confluence with the increasing usage of these sutures in aesthetic plastic surgery procedures, including Brachioplasty, Platysmaplasty, Mastopexy, and brow, midface, and lateral neck suspension, is catalyzing the market growth. Moreover, several technological advancements and rising healthcare expenditure by the governments of various nations are some of the other factors creating a positive market outlook. On account of these factors, IMARC Group expects the market to grow at a CAGR of 5.3% during the forecast period (2024-2032).
Market Summary:
- Based on the type, the market has been bifurcated into absorbable and non-absorbable sutures.
- On the basis of the material, the market has been classified as monofilament and multifilament.
- Based on the application, the market has been divided into cardiovascular, general, gynecological, orthopedic, ophthalmic, and other surgeries.
- The market has been segregated based on the end user into hospitals and clinics, ambulatory surgical centers, and others.
- Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, DemeTECH Corporation, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic plc, Mellon Medical B.V., Smith & Nephew plc, Stryker Corporation, Teleflex Incorporated, and Zimmer Biomet Holdings, Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Type, Material, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, DemeTECH Corporation, Integra LifeSciences, Johnson & Johnson, Medtronic plc, Mellon Medical B.V., Smith & Nephew plc, Stryker Corporation, Teleflex Incorporated and Zimmer Biomet |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800